User profiles for Bhairav S. Paleja

Bhairav Paleja

Senior Scientist
Verified email at vantage-research.net
Cited by 1628

[HTML][HTML] Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis

…, GA D'Agostino, B Ng, WW Lim, J Tan, BS Paleja… - Gastroenterology, 2019 - Elsevier
Background & Aims We studied the role of interleukin 11 (IL11) signaling in the pathogenesis
of nonalcoholic steatohepatitis (NASH) using hepatic stellate cells (HSCs), hepatocytes, …

Fibroblast‐specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease

…, S Viswanathan, AA Widjaja, BS Paleja… - The FASEB …, 2020 - Wiley Online Library
Repetitive pulmonary injury causes fibrosis and inflammation that underlies chronic lung
diseases such as idiopathic pulmonary fibrosis (IPF). Interleukin 11 (IL11) is important for …

IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts

…, BS Paleja, S Schafer, B Reversade, S Albani… - …, 2021 - academic.oup.com
Objectives Interleukin 11 (IL11) is highly upregulated in skin and lung fibroblasts from patients
with systemic sclerosis (SSc). Here we tested whether IL11 is mechanistically linked with …

[HTML][HTML] NLRP10 Enhances CD4+ T-Cell-Mediated IFNγ Response via Regulation of Dendritic Cell-Derived IL-12 Release

…, LP Zambetti, HJ Khameneh, BS Paleja… - Frontiers in …, 2017 - frontiersin.org
NLRP10 is a nucleotide-binding oligomerization domain-like receptor that functions as an
intracellular pattern recognition receptor for microbial products. Here, we generated a Nlrp10 −…

Fibroblast-specific IL11 signaling is required for lung fibrosis and inflammation

B Ng, J Dong, S Viswanathan, AA Widjaja, BS Paleja… - bioRxiv, 2019 - biorxiv.org
… ’s trichrome staining of lung sections were described previously (3). Fibrosis scores in
Masson’s … Primary antibodies concentrations were then applied according to manufacturer’s

IL-11 neutralising therapies target hepatic stellate cell-induced liver inflammation and fibrosis in NASH

…, GA D'Agostino, J Dong, B Ng, J Tan, BS Paleja… - bioRxiv, 2018 - biorxiv.org
The transformation of hepatic stellate cells (HSCs) into myofibroblasts is the defining pathobiology
in non-alcoholic steatohepatitis (NASH). Here we show that key NASH factors induce …

The Extended Polydimensional Immunome Characterization (EPIC) web-based reference and discovery tool for cytometry data

…, S Chiesa, M Gattorno, A Martini, BS Paleja… - Nature …, 2020 - nature.com
… We mapped this cohort’s data directly to EPIC for comparison with the panel B dataset (Fig. …
data, even with an antibody panel only partially matched to EPIC’s (Fig. 3c,d). This approach …

Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis

…, MB Marzuki, X Lu, TW Foreman, B Paleja… - Science …, 2017 - science.org
… P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by two-tailed Student’s t test. Exact P
values are provided in table S8. To identify the possible mechanism(s) underlying the restriction …

[HTML][HTML] Systemic sclerosis perturbs the architecture of the immunome

B Paleja, AHL Low, P Kumar, S Saidin… - Frontiers in …, 2020 - frontiersin.org
… The use, distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication in this journal is …

[HTML][HTML] 1275 Optimizing lipid nano-particle (LNP) design for mRNA drug delivery, efficacy, and dose prediction using mechanistic modeling

BC Narmada, R Dutta, B Paleja, M Channavazzala - 2023 - jitc.bmj.com
… If you wish to reuse any or all of this article please use the link below which will take you to
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …